{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:26:52Z","timestamp":1780450012255,"version":"3.54.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/ncpendmet1050","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T06:53:01Z","timestamp":1232693581000},"page":"113-121","source":"Crossref","is-referenced-by-count":84,"title":["Testosterone and ill-health in aging men"],"prefix":"10.1038","volume":"5","author":[{"given":"Bu B","family":"Yeap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet1050_CR1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/oxfordjournals.aje.a009519","volume":"147","author":"RL Ferrini","year":"1998","unstructured":"Ferrini RL and Barrett-Connor E (1998) Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 147: 750\u2013754","journal-title":"Am J Epidemiol"},{"key":"BFncpendmet1050_CR2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/eje.0.1490145","volume":"149","author":"J Svartberg","year":"2003","unstructured":"Svartberg J et al. (2003) The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso study. Eur J Endocrinol 149: 145\u2013152","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1490583","volume":"149","author":"M Muller","year":"2003","unstructured":"Muller M et al. (2003) Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 149: 583\u2013589","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR4","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1210\/jc.2006-0037","volume":"91","author":"HJ Litman","year":"2006","unstructured":"Litman HJ et al. (2006) Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab 91: 4326\u20134334","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0026-0495(97)90057-3","volume":"46","author":"JE Morley","year":"1997","unstructured":"Morley JE et al. (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46: 410\u2013413","journal-title":"Metabolism"},{"key":"BFncpendmet1050_CR6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM et al. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86: 724\u2013731","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589\u2013598","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2007-0862","volume":"92","author":"PY Liu","year":"2007","unstructured":"Liu PY et al. (2007) Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab 92: 3599\u20133603","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR9","first-page":"1821","volume":"81","author":"A Vermeulen","year":"1996","unstructured":"Vermeulen A et al. (1996) Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81: 1821\u20131826","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2005-1830","volume":"91","author":"E Orwoll","year":"2006","unstructured":"Orwoll E et al. (2006) Testosterone and estradiol in older men. J Clin Endocrinol Metab 91: 1336\u20131344","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1530\/EJE-06-0714","volume":"156","author":"BB Yeap","year":"2007","unstructured":"Yeap BB et al. (2007) In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health In Men Study. Eur J Endocrinol 156: 585\u2013594","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1210\/jcem.84.2.5495","volume":"84","author":"E Barrett-Connor","year":"1999","unstructured":"Barrett-Connor E et al. (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84: 573\u2013577","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR13","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1210\/jc.2006-0679","volume":"91","author":"AL Eriksson","year":"2006","unstructured":"Eriksson AL et al. (2006) SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab 91: 5029\u20135037","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.arr.2007.12.005","volume":"7","author":"JD Veldhuis","year":"2008","unstructured":"Veldhuis JD (2008) Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women. Ageing Res Rev 7: 189\u2013208","journal-title":"Ageing Res Rev"},{"key":"BFncpendmet1050_CR15","first-page":"645","volume-title":"Williams Textbook of Endocrinology","author":"S Bhasin","year":"2008","unstructured":"Bhasin S (2008) Testicular disorders. In Williams Textbook of Endocrinology, edn 11, 645\u2013699 (Eds Kronenberg HM. et al.) Philadelphia: Saunders Elsevier"},{"key":"BFncpendmet1050_CR16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ijir.2008.19","volume":"20","author":"J Svartberg","year":"2008","unstructured":"Svartberg J et al. (2008) Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. Int J Impot Res 20: 378\u2013387","journal-title":"Int J Impot Res"},{"key":"BFncpendmet1050_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2265.2005.02315.x","volume":"63","author":"LA Schaap","year":"2005","unstructured":"Schaap LA et al. (2005) The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol 63: 152\u2013160","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet1050_CR18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2005-1227","volume":"91","author":"AB O'Donnell","year":"2006","unstructured":"O'Donnell AB et al. (2006) Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachussetts Male Aging Study. J Clin Endocrinol Metab 91: 425\u2013431","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.2007-1291","volume":"93","author":"CA Allan","year":"2008","unstructured":"Allan CA et al. (2008) Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 93: 139\u2013146","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR20","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","volume":"90","author":"ST Page","year":"2005","unstructured":"Page ST et al. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90: 1502\u20131510","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR21","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/jc.2006-0173","volume":"91","author":"HA Fink","year":"2006","unstructured":"Fink HA et al. (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91: 3908\u20133915","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archinternmed.2007.2","volume":"168","author":"C Meier","year":"2008","unstructured":"Meier C et al. (2008) Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med 168: 47\u201354","journal-title":"Arch Intern Med"},{"key":"BFncpendmet1050_CR23","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1210\/jc.2007-1469","volume":"93","author":"AB Araujo","year":"2008","unstructured":"Araujo AB et al. (2008) Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J Clin Endocrinol Metab 93: 2135\u20132141","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2265.2005.02339.x","volume":"63","author":"AM Isidori","year":"2005","unstructured":"Isidori AM et al. (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol 63: 280\u2013293","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet1050_CR25","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1210\/jc.2006-0036","volume":"91","author":"MJ Tracz","year":"2006","unstructured":"Tracz MJ et al. (2006) Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 91: 2011\u20132016","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR26","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486\u20132497","DOI":"10.1001\/jama.285.19.2486"},{"key":"BFncpendmet1050_CR27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG et al. (2006) Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23: 469\u2013480","journal-title":"Diabet Med"},{"key":"BFncpendmet1050_CR28","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2004-1158","volume":"90","author":"M Muller","year":"2005","unstructured":"Muller M et al. (2005) Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab 90: 2618\u20132623","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR29","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2006.00963.x","volume":"54","author":"M Maggio","year":"2006","unstructured":"Maggio M et al. (2006) Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc 54: 1832\u20131838","journal-title":"J Am Geriatr Soc"},{"key":"BFncpendmet1050_CR30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-07-0893","volume":"158","author":"SA Chubb","year":"2008","unstructured":"Chubb SA et al. (2008) Lower sex hormone binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health In Men Study. Eur J Endocrinol 158: 785\u2013792","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","volume":"91","author":"V Kupelian","year":"2006","unstructured":"Kupelian V et al. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91: 843\u2013850","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR32","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","volume":"27","author":"DE Laaksonen","year":"2004","unstructured":"Laaksonen DE et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27: 1036\u20131041","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR33","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1210\/jc.2006-2764","volume":"92","author":"A Rodriguez","year":"2007","unstructured":"Rodriguez A et al. (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 92: 3568\u20133572","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/dc06-1579","volume":"30","author":"E Selvin","year":"2007","unstructured":"Selvin E et al. (2007) Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 30: 234\u2013238","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR35","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.295.11.1288","volume":"295","author":"EL Ding","year":"2006","unstructured":"Ding EL et al. (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288\u20131299","journal-title":"JAMA"},{"key":"BFncpendmet1050_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","volume":"25","author":"JY Oh","year":"2002","unstructured":"Oh JY et al. (2002) Endogenous sex hormones and the development of T2DM in older men and women: the Rancho Bernardo study. Diabetes Care 25: 55\u201360","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M et al. (2008) Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab 93: 1834\u20131840","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diacare.27.4.861","volume":"27","author":"EC Tsai","year":"2004","unstructured":"Tsai EC et al. (2004) Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 27: 861\u2013868","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","volume":"28","author":"N Pitteloud","year":"2005","unstructured":"Pitteloud N et al. (2005) Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 28: 1636\u20131642","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2337\/dc06-0919","volume":"30","author":"E Bonora","year":"2007","unstructured":"Bonora E et al. (2007) Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 30: 318\u2013324","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR41","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc06-2152","volume":"30","author":"G de Simone","year":"2007","unstructured":"de Simone G et al. (2007) Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 30: 1851\u20131856","journal-title":"Diabetes Care"},{"key":"BFncpendmet1050_CR42","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1210\/jc.2005-0799","volume":"90","author":"CH Saely","year":"2005","unstructured":"Saely CH et al. (2005) The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 90: 5698\u20135703","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","volume":"115","author":"MW Lorenz","year":"2007","unstructured":"Lorenz MW et al. (2007) Prediction of clinical cardiovascular events with carotid intima\u2013media thickness: a systematic review and meta-analysis. Circulation 115: 459\u2013467","journal-title":"Circulation"},{"key":"BFncpendmet1050_CR44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jacc.2005.01.052","volume":"45","author":"J Makinen","year":"2005","unstructured":"Makinen J et al. (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45: 1603\u20131608","journal-title":"J Am Coll Cardiol"},{"key":"BFncpendmet1050_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/aje\/kwf160","volume":"157","author":"AW van den Beld","year":"2003","unstructured":"van den Beld AW et al. (2003) Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157: 25\u201331","journal-title":"Am J Epidemiol"},{"key":"BFncpendmet1050_CR46","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/01.CIR.0000125854.51637.06","volume":"109","author":"M Muller","year":"2004","unstructured":"Muller M et al. (2004) Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109: 2074\u20132079","journal-title":"Circulation"},{"key":"BFncpendmet1050_CR47","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jcem.87.8.8762","volume":"87","author":"AE Hak","year":"2002","unstructured":"Hak AE et al. (2002) Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 87: 3632\u20133639","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jacc.2007.04.088","volume":"50","author":"A Tivesten","year":"2007","unstructured":"Tivesten A et al. (2007) Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol 50: 1070\u20131076","journal-title":"J Am Coll Cardiol"},{"key":"BFncpendmet1050_CR49","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","volume":"26","author":"JM Kaufman","year":"2005","unstructured":"Kaufman JM and Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26: 833\u2013876","journal-title":"Endocr Rev"},{"key":"BFncpendmet1050_CR50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.01886","volume":"152","author":"A Karagiannis","year":"2005","unstructured":"Karagiannis A and Harsoulis F (2005) Gonadal dysfunction in systemic diseases. Eur J Endocrinol 152: 501\u2013513","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0002-9149(87)91021-6","volume":"60","author":"JA Cauley","year":"1987","unstructured":"Cauley JA et al. (1987) Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol 60: 771\u2013777","journal-title":"Am J Cardiol"},{"key":"BFncpendmet1050_CR52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.CIR.78.3.539","volume":"78","author":"E Barrett-Connor","year":"1988","unstructured":"Barrett-Connor E and Khaw KT (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78: 539\u2013545","journal-title":"Circulation"},{"key":"BFncpendmet1050_CR53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.ATV.13.4.517","volume":"13","author":"JW Yarnell","year":"1993","unstructured":"Yarnell JW et al. (1993) Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arterioscler Thromb 13: 517\u2013520","journal-title":"Arterioscler Thromb"},{"key":"BFncpendmet1050_CR54","volume-title":"Testosterone and Aging: Clinical Research Directions","author":"CT Liverman","year":"2004","unstructured":"Liverman CT and Blazer DG (Eds, 2004) Testosterone and Aging: Clinical Research Directions. Washington, DC, USA: The National Academy Press"},{"key":"BFncpendmet1050_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(11)60964-6","volume":"82","author":"RM Haddad","year":"2007","unstructured":"Haddad RM et al. (2007) Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 82: 29\u201339","journal-title":"Mayo Clin Proc"},{"key":"BFncpendmet1050_CR56","first-page":"3227","volume":"80","author":"H Yki-Jarvinen","year":"1995","unstructured":"Yki-Jarvinen H et al. (1995) Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 80: 3227\u20133232","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/01485010600692017","volume":"52","author":"JA Osuna","year":"2006","unstructured":"Osuna JA et al. (2006) Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 52: 355\u2013361","journal-title":"Arch Androl"},{"key":"BFncpendmet1050_CR58","first-page":"3697","volume":"81","author":"SM Haffner","year":"1996","unstructured":"Haffner SM et al. (1996) Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab 81: 3697\u20133701","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR59","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1210\/jc.2004-0762","volume":"90","author":"T Kalme","year":"2005","unstructured":"Kalme T et al. (2005) Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab 90: 1550\u20131556","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR60","first-page":"2999","volume":"81","author":"D Goodman-Gruen","year":"1996","unstructured":"Goodman-Gruen D and Barrett-Connor E (1996) A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women. J Clin Endocrinol Metab 81: 2999\u20133003","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR61","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.166.15.1660","volume":"166","author":"MM Shores","year":"2006","unstructured":"Shores MM et al. (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166: 1660\u20131665","journal-title":"Arch Intern Med"},{"key":"BFncpendmet1050_CR62","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIRCULATIONAHA.107.719005","volume":"116","author":"KT Khaw","year":"2007","unstructured":"Khaw KT et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men. European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116: 2694\u20132701","journal-title":"Circulation"},{"key":"BFncpendmet1050_CR63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/jc.2007-1792","volume":"93","author":"GA Laughlin","year":"2008","unstructured":"Laughlin GA et al. (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93: 68\u201375","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCULATIONAHA.104.489088","volume":"112","author":"GD Smith","year":"2005","unstructured":"Smith GD et al. (2005) Cortisol, testosterone and coronary heart disease. Prospective evidence from the Caerphilly Study. Circulation 112: 332\u2013340","journal-title":"Circulation"},{"key":"BFncpendmet1050_CR65","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.167.12.1252","volume":"167","author":"AB Araujo","year":"2007","unstructured":"Araujo AB et al. (2007) Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 167: 1252\u20131260","journal-title":"Arch Intern Med"},{"key":"BFncpendmet1050_CR66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-145-3-200608010-00005","volume":"145","author":"J Arnlov","year":"2006","unstructured":"Arnlov J et al. (2006) Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 145: 176\u2013184","journal-title":"Ann Intern Med"},{"key":"BFncpendmet1050_CR67","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","volume":"89","author":"AB Araujo","year":"2004","unstructured":"Araujo AB et al. (2004) Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89: 5920\u20135926","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR68","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","volume":"92","author":"AB Araujo","year":"2007","unstructured":"Araujo AB et al. (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92: 4241\u20134247","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR69","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1532-5415.2008.01679.x","volume":"56","author":"TG Travison","year":"2008","unstructured":"Travison TG et al. (2008) The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission. J Am Geriatr Soc 56: 831\u2013839","journal-title":"J Am Geriatr Soc"},{"key":"BFncpendmet1050_CR70","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1210\/jc.2004-0807","volume":"89","author":"PY Liu","year":"2004","unstructured":"Liu PY et al. (2004) The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89: 4789\u20134796","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR71","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2005-2847","volume":"91","author":"S Bhasin","year":"2006","unstructured":"Bhasin S et al. (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995\u20132010","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5694\/j.1326-5377.2000.tb123913.x","volume":"172","author":"AJ Conway","year":"2000","unstructured":"Conway AJ et al. (2000) Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing. Med J Aust 172: 220\u2013224","journal-title":"Med J Aust"},{"key":"BFncpendmet1050_CR73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2164\/jandrol.05047","volume":"27","author":"E Nieschlag","year":"2006","unstructured":"Nieschlag E et al. (2006) Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 27: 135\u2013137","journal-title":"J Androl"},{"key":"BFncpendmet1050_CR74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2007.03055.x","volume":"68","author":"BB Yeap","year":"2008","unstructured":"Yeap BB et al. (2008) Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health In Men Study. Clin Endocrinol 68: 404\u2013412","journal-title":"Clin Endocrinol"},{"key":"BFncpendmet1050_CR75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archgenpsychiatry.2007.33","volume":"65","author":"OP Almeida","year":"2008","unstructured":"Almeida OP et al. (2008) Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Arch Gen Psychiatry 65: 283\u2013289","journal-title":"Arch Gen Psychiatry"},{"key":"BFncpendmet1050_CR76","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A et al. (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84: 3666\u20133672","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner W et al. (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92: 405\u2013413","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR78","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC et al. (2008) Hypothalamic\u2013pituitary\u2013testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93: 2737\u20132745","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR79","first-page":"657","volume":"9","author":"J Svartberg","year":"2004","unstructured":"Svartberg J et al. (2004) Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 9: 657\u2013663","journal-title":"Eur J Epidemiol"},{"key":"BFncpendmet1050_CR80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.1.02241","volume":"155","author":"BA Mohr","year":"2006","unstructured":"Mohr BA et al. (2006) The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol 155: 443\u2013452","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet1050_CR81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/jc.2006-1859","volume":"92","author":"TG Travison","year":"2007","unstructured":"Travison TG et al. (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92: 549\u2013555","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR82","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1015238102830","volume":"13","author":"NE Allen","year":"2002","unstructured":"Allen NE et al. (2002) Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 13: 353\u2013363","journal-title":"Cancer Causes Control"},{"key":"BFncpendmet1050_CR83","first-page":"735","volume":"4","author":"AH Wu","year":"1995","unstructured":"Wu AH et al. (1995) Serum androgens and sex-hormone binding globulins in relation to lifestyle factors in older African-American, White, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4: 735\u2013741","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFncpendmet1050_CR84","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.metabol.2006.06.019","volume":"55","author":"SYS Wong","year":"2006","unstructured":"Wong SYS et al. (2006) Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong. Metabolism 55: 1488\u20131494","journal-title":"Metabolism"},{"key":"BFncpendmet1050_CR85","doi-asserted-by":"crossref","unstructured":"Yeap BB et al. (2008) Healthier lifestyle predicts higher circulating testosterone in older men. The Health In Men Study. Clin Endocrinol [10.1111\/j.1365-2265.2008.03372.x]","DOI":"10.1111\/j.1365-2265.2008.03372.x"},{"key":"BFncpendmet1050_CR86","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2006-1375","volume":"92","author":"TG Travison","year":"2007","unstructured":"Travison TG et al. (2007) A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92: 196\u2013202","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR87","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1210\/jc.2006-2633","volume":"92","author":"AM Andersson","year":"2007","unstructured":"Andersson AM et al. (2007) Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab 92: 4696\u20134705","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet1050_CR88","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/bies.20051","volume":"26","author":"BB Yeap","year":"2004","unstructured":"Yeap BB et al. (2004) The androgen receptor mRNA. Bioessays 26: 672\u2013682","journal-title":"Bioessays"},{"key":"BFncpendmet1050_CR89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2007.09.004","volume":"18","author":"F Rahman","year":"2007","unstructured":"Rahman F and Christian HC (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18: 371\u2013378","journal-title":"Trends Endocrinol Metab"},{"key":"BFncpendmet1050_CR90","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ncpendmet0477","volume":"3","author":"ME Jones","year":"2007","unstructured":"Jones ME et al. (2007) Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab 3: 414\u2013421","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1050","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet1050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:45:15Z","timestamp":1684867515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet1050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFncpendmet1050"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet1050","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}